Effect of NMSO3 treatment in a murine model of human metapneumovirus infection

Leanne Spetch, Terry L. Bowlin, Antonella Casola

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

BALB/c mice infected with human metapneumovirus (hMPV) were treated with the sulfated sialyl lipid NMSO3 (one dose of 50 mg kg-1) given at the time of infection. NMSO3 significantly reduced viral replication in the lungs, as well as hMPV-induced body weight loss, pulmonary inflammation and cytokine production, suggesting that antiviral treatment initiated at the beginning of viral infection can modify hMPV-induced disease.

Original languageEnglish (US)
Pages (from-to)2709-2712
Number of pages4
JournalJournal of General Virology
Volume89
Issue number11
DOIs
StatePublished - Nov 24 2008

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'Effect of NMSO3 treatment in a murine model of human metapneumovirus infection'. Together they form a unique fingerprint.

  • Cite this